Cresco Labs Inc.
OTC: CRLBF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Charles Bachtell
- Employees
- 2,826
- Headquarters
- Chicago, United States
- IPO year
- 2018
- Market cap
- $272.8M
- Website
- https://www.crescolabs.com
Loading CRLBF…
Loading profile data…Frequently asked questions about CRLBF
What does Cresco Labs Inc. (CRLBF) do?
Cresco Labs Inc. engages in cultivating medical grade cannabis, manufacturing medical products derived from cannabis cultivation, and distributing such products to medical or adult use consumers. It focuses on regulatory compliance while working to develop condition-specific strains of cannabis and non-invasive delivery methods. The company was...
Where does CRLBF trade?
Cresco Labs Inc. (CRLBF) trades on the Other OTC.
What sector is CRLBF in?
Cresco Labs Inc. (CRLBF) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Cresco Labs Inc.?
Charles Bachtell is the chief executive officer of Cresco Labs Inc. (CRLBF).
Where is Cresco Labs Inc. headquartered?
Cresco Labs Inc. is headquartered in United States.
Does CRLBF pay a dividend?
Cresco Labs Inc. (CRLBF) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did CRLBF go public?
Cresco Labs Inc. (CRLBF) completed its initial public offering in 2018.